LONDON (Reuters), Jun 25 - Radiofrequency identification chips (RFID) used to track and trace products could cause critical care medical devices such as pacemakers and ventilators to fail, Dutch researchers said on Tuesday.
Electromagnetic interference from the chips caused 22 problems that could endanger patients, ranging from completely stopping syringe pumps to switching off ventilators, said Erik Jan van Lieshout, a critical care physician at the Academic Medical Centre at the University of Amsterdam.
"We wanted to investigate the safety of RFID in healthcare because it hasn't been tested," Van Lieshout, who co-led the study, told Reuters. "This is the first study ever done on RFID interference within the hospital."
Retailers have embraced RFID and the technology is now moving into healthcare; the researchers estimate spending in the U.S. will grow to $2 billion annually in the next ten years from a current $90 million.
Potential applications include marking drug blister packs to prevent counterfeiting, monitoring blood products with temperature-sensitive blood products, and tracking and tracing important medical equipment and devices, Van Lieshout said.
The potential for harmful electromagnetic interference from electronic anti-theft surveillance systems on some pacemakers and defibrillators is also known but the effect on other critical care devices is not certain, the researchers said.
"Implementation of RFID in the intensive care unit and other similar healthcare environments should require onsite electromagnetic interference tests in addition to updated international standards," Van Lieshout and colleagues wrote in the Journal of the American Medical Association.
The Dutch team tested electromagnetic interference of the two most common RFID systems in a one-bed patient room in an intensive care unit with no patients.
Their tests on 41 devices identified 22 hazardous incidents, two they classified as significant and another 10 as light. Most of the hazardous incidents occurred at about 9.8 inches from the equipment, though they recorded problems up to six meters away.
A hazardous incident was a problem that could directly endanger a patient while a significant incident was one requiring a nurse's attention but not something that put a person at immediate risk.
The findings should not dissuade hospitals from using a technology but they underscore the need to make sure wireless signals are safe for patients, Van Lieshout added.
"We don't want to induce a ban on RFID in healthcare because it has real potential," he said. "But like other wireless signals it could endanger your equipment, and thus your patient."
By Michael Kahn
Last Updated: 2008-06-24 16:01:18 -0400 (Reuters Health)
Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
